86842067 - ZEALAND PHARMA A/S

Information

  • Trademark
  • 86842067
  • Serial Number
    86842067
  • Registration Number
    5597662
  • Filing Date
    December 08, 2015
    8 years ago
  • Registration Date
    October 30, 2018
    5 years ago
  • Transaction Date
    October 30, 2023
    6 months ago
  • Status Date
    October 30, 2018
    5 years ago
  • Location Date
    October 30, 2018
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KEELEY, ALISON REBECCA
  • Attorney Docket Number
    31914-394205
    Attorney Name
    Rebecca A. Liebowitz
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4000
Mark Identification
ZEALAND PHARMA A/S
Case File Statements
  • GS0051: (Based on Section 44(e)) Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders
  • GS0011: (Based on Section 44(e)) Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
  • GS0441: (Based on Section 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dentistry services; medical analysis of peptide based medicines for the diagnosis and treatment of persons; pharmaceutical advice; medical consulting services in the field of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders
  • D10000: "PHARMA A/S"
  • GS0421: (Based on Section 44(e)) Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology, namely, research, design of peptides and pharmaceutical drugs, medical and scientific laboratory services, scientific and medical research consulting services, and medical research, analysis and testing in the field of diseases, illnesses and ailments in humans and animals for scientific and research purposes, namely, in the fields of endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, and skin disorders; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; design and development of computer hardware and software; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services, namely, the development of medicines for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid, namely, information and consultancy services relating to the development of medicines for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders
Case File Event Statements
  • 10/30/2023 - 6 months ago
    51 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 6/23/2022 - a year ago
    50 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 2/4/2022 - 2 years ago
    49 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 11/23/2021 - 2 years ago
    48 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/23/2021 - 2 years ago
    47 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/23/2021 - 2 years ago
    46 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 11/23/2021 - 2 years ago
    45 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/23/2021 - 2 years ago
    44 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/23/2021 - 2 years ago
    43 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/30/2018 - 5 years ago
    42 - REGISTERED-SUPPLEMENTAL REGISTER Type: R.SR
  • 9/25/2018 - 5 years ago
    41 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 9/25/2018 - 5 years ago
    40 - APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Type: CNTA
  • 9/24/2018 - 5 years ago
    39 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/24/2018 - 5 years ago
    38 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/24/2018 - 5 years ago
    37 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 5/29/2018 - 5 years ago
    36 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED Type: GNS1
  • 5/29/2018 - 5 years ago
    35 - SUBSEQUENT FINAL EMAILED Type: GNSF
  • 5/29/2018 - 5 years ago
    34 - SUBSEQUENT FINAL REFUSAL WRITTEN Type: CFRC
  • 5/8/2018 - 6 years ago
    33 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/6/2018 - 6 years ago
    32 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/5/2018 - 6 years ago
    31 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/5/2018 - 6 years ago
    30 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/21/2017 - 6 years ago
    29 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 11/21/2017 - 6 years ago
    28 - PRIORITY ACTION E-MAILED Type: GPRA
  • 11/21/2017 - 6 years ago
    27 - PRIORITY ACTION WRITTEN Type: CPRA
  • 10/27/2017 - 6 years ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/27/2017 - 6 years ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/23/2017 - 6 years ago
    24 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 4/28/2017 - 7 years ago
    23 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/28/2017 - 7 years ago
    22 - FINAL REFUSAL E-MAILED Type: GNFR
  • 4/28/2017 - 7 years ago
    21 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/6/2017 - 7 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/6/2017 - 7 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/6/2017 - 7 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/25/2017 - 7 years ago
    17 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/23/2017 - 7 years ago
    16 - ASSIGNED TO LIE Type: ALIE
  • 12/29/2016 - 7 years ago
    15 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 10/7/2016 - 7 years ago
    14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/7/2016 - 7 years ago
    13 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/7/2016 - 7 years ago
    12 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/16/2016 - 7 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/16/2016 - 7 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/16/2016 - 7 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/16/2016 - 7 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/16/2016 - 7 years ago
    7 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 3/30/2016 - 8 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/30/2016 - 8 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/30/2016 - 8 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/25/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/11/2015 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/11/2015 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP